Evidence map›Paper›PMID 41011786›Full record

ArticlePathogens (Basel, Switzerland)2025

Anti-Rickettsial Activity of Chitosan, Selenium, and Silver Nanoparticles: Efficacy in Vero Cells.

Yevheniy-Yuliy Peresh, Zdenko Špitalský, Mohamed Shaalan, Eva Špitalská

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yevheniy-Yuliy PereshInstitute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Dúbravská cesta 9, 845 05 Bratislava, Slovakia.
Zdenko ŠpitalskýInstitute of Polymer, Slovak Academy of Sciences, Dúbravská cesta 9, 845 41 Bratislava, Slovakia.ORCID 0000-0003-2589-9035
Mohamed ShaalanInstitute of Polymer, Slovak Academy of Sciences, Dúbravská cesta 9, 845 41 Bratislava, Slovakia.
Eva ŠpitalskáInstitute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Dúbravská cesta 9, 845 05 Bratislava, Slovakia.ORCID 0000-0002-6138-7136

Funding

Recovery and Resilience Plan of the Slovak Republic 09I03-03-V04-00556Scientific Grant Agency of the Ministry of Education and Slovakian Academy of Sciences VEGA 2/0011/25Slovakian Research and Development Agency APVV-23-0325
6 · The paper itself

Abstract

Nanoparticles have emerged as innovative tools for combating bacterial infections, offering a potential solution to antibiotic resistance and the limitations of conventional antimicrobials. Nanoparticles exhibit antibacterial activity through multiple mechanisms, including oxidative stress induction, metal ion release, direct membrane damage, disruption of DNA and proteins, and indirect immune system enhancement.

Indexed as

Anti-Bacterial AgentsChitosanMetal NanoparticlesRickettsia conoriiSeleniumSilverAnimalsChlorocebus aethiopsRickettsia InfectionsVero CellsAnti-Bacterial AgentsChitosanSeleniumSilverhost cellsnanoparticlesRickettsia speciestherapyticktick-borne pathogen

Identifiers

PMID41011786
PMCPMC12472819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.